Wellington Management Group
PGNX

Wellington Management Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Wellington Management Group’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-521,025
Closed -$3.54M – 2332
2017
Q2 		$3.54M Buy
521,025
+299,944
+136% +$2.21M ﹤0.01% 1540
2017
Q1 		$2.09M Buy
221,081
+130,046
+143% +$1.3M ﹤0.01% 1728
2016
Q4 		$786K Buy
+91,035
New +$673K ﹤0.01% 1918
2016
Q2 		– Sell
-36,100
Closed -$157K – 2219
2016
Q1 		$157K Sell
36,100
-361,673
-91% -$1.61M ﹤0.01% 2084
2015
Q4 		$2.44M Sell
397,773
-453,321
-53% -$2.97M ﹤0.01% 1572
2015
Q3 		$4.87M Sell
851,094
-798,193
-48% -$6.12M ﹤0.01% 1366
2015
Q2 		$12.3M Buy
1,649,287
+170,860
+12% +$1.03M ﹤0.01% 1164
2015
Q1 		$8.84M Buy
1,478,427
+32,750
+2% +$206K ﹤0.01% 1282
2014
Q4 		$10.9M Sell
1,445,677
-60,057
-4% -$359K ﹤0.01% 1214
2014
Q3 		$7.82M Sell
1,505,734
-63,370
-4% -$316K ﹤0.01% 1315
2014
Q2 		$6.76M Buy
1,569,104
+23,490
+2% +$89.7K ﹤0.01% 1366
2014
Q1 		$6.32M Buy
1,545,614
+741,880
+92% +$3.79M ﹤0.01% 1380
2013
Q4 		$4.28M Sell
803,734
-79,400
-9% -$349K ﹤0.01% 1508
2013
Q3 		$4.44M Sell
883,134
-459,070
-34% -$2.49M ﹤0.01% 1466
2013
Q2 		$5.99M Buy
+1,342,204
New +$6.02M ﹤0.01% 1374

Other funds holding PGNX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Wellington Management Group's PGNX Position: Q3 2017 in Review

Wellington Management Group sold out of Progenics Pharmaceuticals Inc (PGNX) in Q3 2017, closing a stake of 521,025 shares — an estimated $3.54M sold.

Wellington Management Group first reported a position in PGNX in Q2 2013 and held it in 15 quarters. The position peaked at $12.3M in Q2 2015. 142 funds tracked by Wall St. Rank hold PGNX as of Q3 2017.

  • Wellington Management Group reported no remaining Progenics Pharmaceuticals Inc position as of Q3 2017 after selling out during the quarter.
  • Wellington Management Group sold 521,025 Progenics Pharmaceuticals Inc shares in Q3 2017, an estimated $3.54M.
  • Wellington Management Group first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Wellington Management Group's Progenics Pharmaceuticals Inc position peaked at $12.3M in Q2 2015.
  • 142 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q3 2017.

Based on Wellington Management Group's 13F filing for Q3 2017, filed 13 Nov 2017.